001     288741
005     20250814140816.0
024 7 _ |a 10.1016/j.euo.2024.02.004
|2 doi
024 7 _ |a pmid:38418266
|2 pmid
037 _ _ |a DKFZ-2024-00444
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Classon, Johanna
|b 0
245 _ _ |a The Role of Cytomegalovirus in Prostate Cancer Incidence and Mortality.
260 _ _ |a Amsterdam
|c 2024
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1730277214_11638
|2 PUB:(DE-HGF)
|x Editorial
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Oct;7(5):1144-1146 / or letter
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Britten, Abigail
|b 1
700 1 _ |a Alkass, Kanar
|b 2
700 1 _ |a Druid, Henrik
|b 3
700 1 _ |a Brenner, Nicole
|0 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
|b 4
|u dkfz
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 5
|u dkfz
700 1 _ |a Wareham, Nicholas J
|b 6
700 1 _ |a Gkrania-Klotsas, Effrossyni
|b 7
700 1 _ |a Frisén, Jonas
|b 8
773 _ _ |a 10.1016/j.euo.2024.02.004
|g p. S2588931124000488
|0 PERI:(DE-600)2945338-0
|n 5
|p 1144-1146
|t European urology oncology
|v 7
|y 2024
|x 2588-9311
856 4 _ |u https://inrepo02.dkfz.de/record/288741/files/1-s2.0-S2588931124000488-main.pdf
856 4 _ |u https://inrepo02.dkfz.de/record/288741/files/1-s2.0-S2588931124000488-main.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:inrepo02.dkfz.de:288741
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)b1326dc42cbbc5f92b10fe5f254f0bc2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR UROL ONCOL : 2022
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-25
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-25
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR UROL ONCOL : 2022
|d 2023-08-25
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)D320-20160331
|k D320
|l Infektionen und Krebs-Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a I:(DE-He78)D320-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21